Table 2. Hepatitis B birth dose coverage, institutional births, and antenatal care visits in the 5 African countries with birth dose assessments.
| Country | % HBsAg prevalence (min %, max %) | Year HepB-BD introduced | Annual Births (1000s)1 | Institutional deliveries %2 | Births attended by SBA %2 | >1 ANC visit %2 |
|---|---|---|---|---|---|---|
| Botswana | 5.3, 10.6 (35–37) | Pre 2000 | 55 | 100 | 95 | 94 |
| Gambia | 8.5, 9.1 (38–40) | 1990 | 83 | 63 | 57 | 86 |
| Namibia | 7.8, 13.6 (41–43) | 2014 | 72 | 87 | 88 | 97 |
| Nigeria | 6.7, 17.2 (44–46) | 2004 | 7,133 | 36 | 38 | 61 |
| Sao Tome and Principe3 | 6.1, 10 (47) | 2002 | 6 | 91 | 93 | 98 |
1
Annual birth data is derived from the WHO Immunization Monitoring System (updated May 2016) http://apps.who.int/immunization_monitoring/globalsummary.
2
Data derived from UNICEF (updated February 2016) www.data.unicef.org
3
Sao Tome and Principe does not offer the birth dose universally, but follow a selective policy where infants of mothers that test HBsAg are offered vaccine